Recent Company News

• 01:41 PM ET Dec 05, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 07-Dec

• 05:34 PM ET Dec 03, 2025
  

  A Threat to Evidence-Based Vaccine Policy and Public Health Security at the FDA - NEJM (OpEd)

• 09:05 AM ET Dec 03, 2025
  

  BioNTech (BNTX) announces achievement of minimum condition in exchange offer for CureVac ($5.11, 0.00)

• 05:00 PM ET Dec 01, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:51 AM ET Dec 01, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:29 AM ET Dec 01, 2025
  

  FDA CBER Director Vinay Prasad issues internal memo linking death of 10 children to Covid-19 vaccines - NYT (28-Nov, post-close) ($25.98, 0.00)

• 12:00 PM ET Nov 28, 2025
  

  StreetAccount Summary - U.S. Unusual Option Volume

• 11:44 AM ET Nov 28, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 30-Nov

• 07:11 PM ET Nov 25, 2025
  

  CureVac shareholders approve proposals relating to BioNTech SE's public exchange offer ($5.28, 0.00)

• 09:23 PM ET Nov 21, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap